Skip to main navigation Skip to search Skip to main content

Definition of Severity and Relapse for Vitiligo: An International Consensus Statement

  • Viktoria Eleftheriadou
  • , Seemal Desai
  • , Jung Min Bae
  • , Stephen Taylor
  • , Jean Marie Meurant
  • , Marwa Abdallah
  • , Hyun Jeong Ju
  • , Laïla Benzekri
  • , Albert Wolkerstorfer
  • , Markus Böhm
  • , Leihong F. Xiang
  • , Emma Rush
  • , Iltefat H. Hamzavi
  • , Thierry Passeron
  • , Henry Lim
  • , John E. Harris
  • , Davinder Parsad
  • , Richard Huggins
  • , Alexandre Schneider
  • , Antonios Kolios
  • David Rosmarin, Tasneem F. Mohammad, Samia M. Esmat, Janet Jones, Ameeta Retzer, Julien Seneschal, Maria Angeliki Gkini, Alia Ahmed, Andrew Thompson, Amit G. Pandya, Samantha Cruz Rivera, Fanny C. Kpenou, Khaled Ezzedine
  • Royal Wolverhampton Hospitals NHS Trust
  • Walsall Healthcare NHS Trust
  • University of Birmingham
  • University of Texas Southwestern Medical Center
  • Innovative Dermatology
  • The Catholic University of Korea, St. Vincent's Hospital
  • Vitiligo International Patient Organizations Committee
  • Ain Shams University
  • Mohammed V University in Rabat
  • Amsterdam University Medical Center
  • University of Münster
  • Fudan University
  • Vitiligo Support Group
  • Henry Ford Health System
  • CHU de Nice
  • Centre Méditerranéen de Médecine Moléculaire
  • University of Massachusetts Medical School
  • Postgraduate Institute of Medical Education and Research
  • Vitiligo Society
  • University of Zurich
  • University of Bern
  • Indiana University Bloomington
  • Cairo University
  • Bordeaux University
  • Université de Bordeaux
  • Barts Health NHS Trust
  • Cardiff & Vale University Health Board
  • The British Psychological Society
  • Palo Alto Foundation Medical Group
  • Université Paris-Est Créteil
  • School of Public Health
  • Hôpital Henri Mondor

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Importance There is no international consensus on defining vitiligo severity or relapse. Current measures (such as body surface area) quantify depigmentation but do not fully capture the broader clinical and psychosocial effects of the disease. Objective To develop internationally agreed-upon definitions and criteria for vitiligo severity and relapse as part of the International Consensus on Definition of Severity and Relapse in Vitiligo study. Evidence Review This global, mixed-methods consensus study used a multistep approach, including comprehensive literature review, qualitative study, 2 rounds of electronic Delphi surveys, and a final consensus meeting. To ensure adequate diversity and inclusivity and to capture a broad range of experiences, perspectives, social contexts, and representation, a recruitment framework (encompassing variation in age, sex, and skin phototypes) was predefined. Findings In total, 91 people from 5 continents expressed interest in participating. Experts (dermatologists, trialists, methodologists, nurses, psychologists, journal editors, and researchers) and people with vitiligo from diverse ethnic backgrounds and skin phototypes took part. During the first electronic Delphi survey round, 85 people participated and 81 participated in round 2 (response rate of 95% in each survey round). Consensus was reached that even though measurement of body surface area remains a necessary and adequate starting point for assessing vitiligo severity, this measure alone is insufficient to capture disease burden. The final consensus meeting included 44 participants (response rate of 54%). Twelve criteria for upgrading severity were recommended, encompassing both clinical aspects of vitiligo and its psychosocial effects. The major criteria for vitiligo include spread or active disease, involvement of highly visible or high-impact areas, psychological distress, stigmatization, lack of self-acceptance, and overall burden. The minor criteria for vitiligo include darker skin tones, younger age, involvement of scalp/facial hair, increased risk of sunburn, impact on career or school, and perceived loss of personal or cultural identity. No consensus was reached on the extent of pigment loss. Relapse was defined as loss of pigmentation in previously repigmented lesions (repigmentation had occurred either spontaneously or with treatment). Conclusion and Relevance This global, mixed-methods consensus study established internationally agreed-upon severity criteria for vitiligo. This consensus aims to bridge the gap between physician assessment and patient experience; improve the relevance and consistency of the severity classification in clinical care, research, and regulatory frameworks; and help close the remaining gaps in the diagnosis and classification of vitiligo.

Original languageEnglish
Pages (from-to)515-524
Number of pages10
JournalJAMA Dermatology
Volume162
Issue number5
DOIs
StatePublished - 20 May 2026

Bibliographical note

Publisher Copyright:
© 2026 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies.

Fingerprint

Dive into the research topics of 'Definition of Severity and Relapse for Vitiligo: An International Consensus Statement'. Together they form a unique fingerprint.

Cite this